Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
Sage Therapeutics said Wednesday its Biogen-partnered treatment for essential tremor failed in a study, leading Sage stock to collapse. The post Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails appeared first on Investor's Business Daily.
Sage Therapeutics said Wednesday its Biogen-partnered treatment for essential tremor failed in a study, leading Sage stock to collapse.
The post Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
